NCT06268704View on ClinicalTrials.gov

Particulate Vs. Non-Particulate Steroid for Sacroiliac Joint Injection

PHASE4RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

May 1, 2027

Conditions
Sacroiliac Joint DysfunctionSacro-Iliac Spondylosis
Interventions
DRUG

Dexamethasone

This is a non-particulate steroid commonly used to treat SI joint pain.

DRUG

Methylprednisolone

This is a particulate steroid commonly used to treat SI joint pain.

DRUG

2% Lidocaine HCl Injection

Lidocaine is a local anesthetic used in SI joint injection procedures to numb the procedure site and helps to confirm SI joint dysfunction when injected with the steroid medication into the SI joint.

Trial Locations (1)

87131

RECRUITING

University of New Mexico Hospital, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER